New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma. [electronic resource]
Producer: 20191021Description: 646-650 p. digitalISSN:- 1540-1413
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- antagonists & inhibitors
- Brachytherapy -- methods
- Costimulatory and Inhibitory T-Cell Receptors -- antagonists & inhibitors
- Disease Progression
- Disease-Free Survival
- Eye Enucleation -- methods
- Liver Neoplasms -- genetics
- Lymphatic Metastasis -- pathology
- Medical Oncology -- standards
- Melanoma -- genetics
- Neoadjuvant Therapy -- methods
- Neoplasm Recurrence, Local -- genetics
- Neoplasm Staging
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Skin Neoplasms -- genetics
- Societies, Medical -- standards
- United States
- Uveal Neoplasms -- genetics
- Uveal Melanoma
No physical items for this record
Publication Type: Journal Article; Practice Guideline
There are no comments on this title.
Log in to your account to post a comment.